NovoCure20Limited  (NVCR) - NASDAQGS

  Revenue / EPS Summary *  
 
 Fiscal Quarter 2018
(Fiscal Year)
2017
(Fiscal Year)
2016
(Fiscal Year)
March      
   Revenue $52,125(t) $34,880(t) $13,053(t)
   EPS -0.23 (3/31/2018) -0.21 (3/31/2017) -0.42 (3/31/2016)
   Dividends N/A N/A N/A
June      
   Revenue $61,514(t) $38,376(t) $17,919(t)
   EPS -0.17 (6/30/2018) -0.24 (6/30/2017) -0.48 (6/30/2016)
   Dividends N/A N/A N/A
September      
   Revenue $64,756(t) $50,109(t) $21,674(t)
   EPS -0.12 (9/30/2018) -0.12 (9/30/2017) -0.39 (9/30/2016)
   Dividends N/A N/A N/A
December  (FYE)      
   Revenue $69,674(t) $53,661(t) $30,242(t)
   EPS -0.17 (12/31/2018) -0.13 (12/31/2017) -0.25 (12/31/2016)
   Dividends N/A N/A N/A
Totals      
   Revenue $248,069(t) $177,026(t) $82,888(t)
   EPS -0.69 -0.7 -1.54
   Dividends N/A N/A N/A
Next 3 Years    Previous 3 Years
 
 
©2021, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.